All In Biotech

Drug Trial Radar · NCT07520565

A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.

Last checked: Nov 19, 2026Latest source record: Apr 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,112 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,112

Planned (sponsor's estimate)

Start

Jan 19, 2026

Primary completion

Jul 2027

Study completion Dec 2027

Sponsor

Sponsor type
Industry
First posted
Apr 9, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to evaluate the efficacy of early administration of BXOS110 for injection in reducing overall disability in patients with acute ischaemic stroke

Conditions

  • AIS

Interventions

  • BXOS110Drug

    BXOS110,Intravenous infusion administration once,3.0 mg/kg, with a maximum dose of up to 300 mg

  • placeboDrug

    placebo,Intravenous infusion administration once,3.0 mg/kg, with a maximum dose of up to 300 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects with mRS score 0-2 on day 90Time frame: day 90(on the day 90 after treatment)

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Tiantan Hospital , Capital Medical University

    Beijing, China · Not yet recruiting

  • Harrison International Peace Hospital

    Hengshui, Hebei, China · Recruiting

  • Daqing Oilfield General Hospital

    Daqing, Heilongjiang, China · Recruiting

  • The First Affiliated Hospital of Nanyang Medicinal College

    Nanyang, Henan, China · Recruiting

  • MeiHekou Central Hospital

    Meihekou, Jilin, China · Recruiting

  • The Affiliated Hospital of Shenyang Medical College

    Shenyang, Liaoning, China · Recruiting

  • Xianyang Hospital of Yan'an University

    Xianyang, Shaanxi, China · Recruiting

  • Linyi People's Hospital

    Linyi, Shandong, China · Recruiting

  • Linfen Central Hospital

    Linfen, Shanxi, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.